Desmethylsibutramine
Desmethylsibutramine is a chemical compound that is structurally related to sibutramine, a drug that was previously used as an appetite suppressant for the treatment of obesity. Desmethylsibutramine is one of the primary active metabolites of sibutramine, which means it is formed in the body when sibutramine is metabolized.
Chemical Structure and Properties[edit]
Desmethylsibutramine belongs to the class of compounds known as phenethylamines. Its chemical structure is similar to that of sibutramine, with the primary difference being the absence of a methyl group. This structural modification results in different pharmacological properties compared to the parent compound.
Pharmacology[edit]
Desmethylsibutramine acts as a serotonin-norepinephrine reuptake inhibitor (SNRI). This means it inhibits the reuptake of the neurotransmitters serotonin and norepinephrine, leading to increased levels of these chemicals in the brain. This mechanism is believed to contribute to its appetite-suppressing effects.
Medical Use[edit]
While sibutramine was approved for medical use in the treatment of obesity, desmethylsibutramine itself is not approved as a medication. Sibutramine was withdrawn from the market in many countries due to concerns about its cardiovascular safety profile, including increased risks of heart attack and stroke.
Legal Status[edit]
Due to its structural similarity to sibutramine and its potential for similar effects, desmethylsibutramine is often regulated under the same legal frameworks as sibutramine. In many jurisdictions, it is classified as a controlled substance, making its manufacture, distribution, and possession subject to legal restrictions.
Safety and Side Effects[edit]
The safety profile of desmethylsibutramine is not well-documented, but it is likely to share similar side effects with sibutramine. These may include increased heart rate, elevated blood pressure, dry mouth, constipation, and insomnia. Due to the potential for serious cardiovascular side effects, the use of desmethylsibutramine is not recommended.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
